NO165493C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner.

Info

Publication number
NO165493C
NO165493C NO873514A NO873514A NO165493C NO 165493 C NO165493 C NO 165493C NO 873514 A NO873514 A NO 873514A NO 873514 A NO873514 A NO 873514A NO 165493 C NO165493 C NO 165493C
Authority
NO
Norway
Prior art keywords
india
pyridopyrimid
chinazol
preparation
therapeutically active
Prior art date
Application number
NO873514A
Other languages
English (en)
Norwegian (no)
Other versions
NO873514D0 (no
NO873514L (no
NO165493B (no
Inventor
John Adams Lowe Iii
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO873514D0 publication Critical patent/NO873514D0/no
Publication of NO873514L publication Critical patent/NO873514L/no
Publication of NO165493B publication Critical patent/NO165493B/no
Publication of NO165493C publication Critical patent/NO165493C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
NO873514A 1986-08-21 1987-08-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner. NO165493C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/001718 WO1988001270A1 (en) 1986-08-21 1986-08-21 Pyridopyrimidinediones

Publications (4)

Publication Number Publication Date
NO873514D0 NO873514D0 (no) 1987-08-20
NO873514L NO873514L (no) 1988-02-22
NO165493B NO165493B (no) 1990-11-12
NO165493C true NO165493C (no) 1991-02-20

Family

ID=22195608

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873514A NO165493C (no) 1986-08-21 1987-08-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner.

Country Status (25)

Country Link
US (1) US4797403A (xx)
JP (1) JPH0625166B2 (xx)
KR (1) KR900003497B1 (xx)
CN (1) CN1014992B (xx)
AR (1) AR243513A1 (xx)
AT (1) AT388378B (xx)
AU (1) AU579047B2 (xx)
CA (1) CA1294618C (xx)
CS (1) CS268189B2 (xx)
DD (1) DD261598A5 (xx)
DK (1) DK433787A (xx)
EG (1) EG18270A (xx)
FI (1) FI84720C (xx)
HU (1) HU196798B (xx)
IE (1) IE59937B1 (xx)
IL (1) IL83569A (xx)
MX (1) MX7829A (xx)
MY (1) MY101821A (xx)
NO (1) NO165493C (xx)
NZ (1) NZ221502A (xx)
PH (1) PH23853A (xx)
PT (1) PT85555B (xx)
RU (1) RU1769758C (xx)
WO (1) WO1988001270A1 (xx)
ZA (1) ZA876172B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260817B1 (en) * 1986-08-21 1991-05-15 Pfizer Inc. Quinazolinediones and pyridopyrimidinediones
US5290780A (en) * 1991-01-30 1994-03-01 American Cyanamid Co. Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
NZ322197A (en) * 1995-11-21 1999-02-25 Yamanouchi Pharma Co Ltd Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
SA08280783B1 (ar) * 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
FR2943673B1 (fr) * 2009-03-27 2013-03-29 Sanofi Aventis Applications therapeutiques de derives de quinazolinedione
WO2012125521A1 (en) * 2011-03-14 2012-09-20 Eternity Bioscience Inc. Quinazolinediones and their use
TWI527800B (zh) 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚（二磷酸腺苷酸－核醣）聚合酶（ｐａｒｐ）之抑制劑之１－（芳基甲基）喹唑啉－２，４（１ｈ，３ｈ）－二酮及其應用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH490801A (de) * 1968-02-27 1970-05-31 Ciba Geigy Schädlingsbekämpfungsmittel und dessen Verwendung
US3794643A (en) * 1971-04-20 1974-02-26 Hisamitsu Pharmaceutical Co Quinazolinedione derivatives
GB1401549A (en) * 1972-07-07 1975-07-16 Hisamitsu Pharmaceutical Co Pyrido-2,3-d-pyrimidine-2,4-1h,3h- diones and methods of preparing them
US3922275A (en) * 1972-11-09 1975-11-25 Hisamitsu Pharmaceutical Co Pyrido{8 2,3-D{9 {0 pyrimidine-2,4(1H,3H)-diones
JPS5069096A (xx) * 1973-10-25 1975-06-09
JPS5649917B2 (xx) * 1973-12-18 1981-11-25
JPS5849559B2 (ja) * 1974-02-19 1983-11-05 ヒサミツセイヤク カブシキガイシヤ シンキナ ピリドピリミジンジオンユウドウタイノ セイゾウホウ
JPS50116493A (xx) * 1974-02-20 1975-09-11
JPS50157393A (xx) * 1974-05-24 1975-12-19
JPS5813551B2 (ja) * 1975-03-15 1983-03-14 ヒサミツセイヤク カブシキガイシヤ シンキナピリド （ ４，３−ｄ ） ピリミジンジオンユウドウタイノセイゾウホウ
US4266056A (en) * 1978-04-07 1981-05-05 Zoecon Corporation Phenyl uracils
DK167280B1 (da) * 1985-03-20 1993-10-04 Ciba Geigy Ag 3-aryluracilderivater, fremgangsmaade til fremstilling deraf, ukrudtsbekaempelsesmidler indeholdende disse derivater samt anvendelsen af derivaterne til ukrudtsbekaempelse
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives

Also Published As

Publication number Publication date
NZ221502A (en) 1989-11-28
FI84720C (fi) 1992-01-10
DD261598A5 (de) 1988-11-02
DK433787A (da) 1988-02-22
MY101821A (en) 1992-01-31
MX7829A (es) 1993-08-01
CS268189B2 (en) 1990-03-14
NO873514D0 (no) 1987-08-20
CN87105791A (zh) 1988-03-09
CN1014992B (zh) 1991-12-04
CA1294618C (en) 1992-01-21
DK433787D0 (da) 1987-08-20
PT85555B (pt) 1990-05-31
FI873608A (fi) 1988-02-22
AT388378B (de) 1989-06-12
KR880002868A (ko) 1988-05-12
JPH0625166B2 (ja) 1994-04-06
ZA876172B (en) 1989-03-29
RU1769758C (en) 1992-10-15
JPS6360974A (ja) 1988-03-17
PH23853A (en) 1989-11-23
CS597487A2 (en) 1989-05-12
NO873514L (no) 1988-02-22
EG18270A (en) 1992-12-30
HUT44786A (en) 1988-04-28
KR900003497B1 (ko) 1990-05-21
NO165493B (no) 1990-11-12
HU196798B (en) 1989-01-30
PT85555A (en) 1987-09-01
IE59937B1 (en) 1994-05-04
ATA263087A (de) 1988-11-15
IE872239L (en) 1989-01-20
AU579047B2 (en) 1988-11-10
US4797403A (en) 1989-01-10
AU7724787A (en) 1988-03-10
FI873608A0 (fi) 1987-08-20
IL83569A (en) 1991-12-15
WO1988001270A1 (en) 1988-02-25
FI84720B (fi) 1991-09-30
AR243513A1 (es) 1993-08-31
IL83569A0 (en) 1988-01-31

Similar Documents

Publication Publication Date Title
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO166184C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n9-cyklopentyl-substituerte adeninderivater.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO162189C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO157738C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO173653C (no) Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO871028D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
NO162860C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzo-(pyrano og tiopyrano)-pyridiner.
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
NO165493C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolindioner og pyridopyrimidindioner.
NO894949L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees